HNGE vs CI Stock Comparison

Hinge Health and Cigna Prices as of Nov 16, 2026 Peers: Industry group
HNGE Hinge Health, Inc.
$121.24 +22.2% 1M +196.0% 1Y
Market cap
$9.19B
P/E
55.1x
Revenue (TTM)
$800.82M
Div. yield
–
Telehealth Healthcare
4 wins
CI Cigna Group
$300.17 -0.8% 1M +11.3% 1Y
Market cap
$77.24B
P/E
12.9x
Revenue (TTM)
$286.32B
Div. yield
0.02%
Managed Care Healthcare
4 wins

Head to Head

8 decided of 12

Cigna leads on 4 of the 12 questions below (Cigna 4, Hinge Health 4). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionHNGECILeader
Larger companyMarket capitalisation $9.19B $77.24B CI
Cheaper on earningsLower P/E, profitable companies only 55.1x 12.9x CI
Cheaper on forward earningsLower price / next fiscal year consensus EPS 42.9x 9.1x CI
Faster revenue growthRevenue growth, trailing twelve months +49.9% +6.8% HNGE
More profitableNet margin, trailing twelve months 20.8% 2.1% HNGE
Better return on capitalReturn on invested capital — 10.4% –
Less leveragedLower net debt / EBITDA — 1.9x –
Higher dividend yieldTrailing dividend yield 0.00% 0.02% –
Better 1-year returnPrice return, last 12 months +196.0% +11.3% HNGE
Better 5-year returnAnnualised price return, 5 years — +6.7%/yr –
Less volatileAnnualised volatility, 1 year 51.1% 27.1% CI
Higher overall scoreMean of the five percentile scores vs peers 70/100 63/100 HNGE

Percentile Scorecard

HNGECI

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisHNGECI
Valuation 27 #73 of 99 89 #4 of 27
Growth 97 #4 of 89 40 #16 of 26
Profitability 99 #2 of 92 68 #9 of 26
Financial Health 45 #57 of 103 32 #18 of 26
Shareholder Returns 84 #11 of 63 88 #3 of 18
Overall 70 63
  • HNGE ranked among 103 companies in Healthcare Providers
  • CI ranked among 27 companies in Healthcare Payers and Distributors

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodHNGECISPY
1 month +22.2%-0.8% -3.0%
3 months +37.9%+9.0% -4.2%
6 months +121.6%+4.7% +0.2%
Year to date +161.0%+9.1% +8.5%
1 year +196.0%+11.3% +10.1%
3 years —+6.2% +64.1%
3 years, per year —+2.0% +18.0%
5 years —+38.3% +58.1%
5 years, per year —+6.7% +9.6%
10 years —+117.7% +239.6%
10 years, per year —+8.1% +13.0%

Risk

MeasureHNGECISPY
Volatility, 1Y 51.1%27.1% 13.8%
Downside volatility, 1Y 47.1%26.8% 14.2%
Beta vs S&P 500, 1Y 1.110.07 1.00
Return / volatility, 1Y 3.840.42 0.74
Max drawdown, 5Y -48.5%-33.4% -25.4%
From 52-week high -1.6%-5.0% -5.0%
52-week high $123.17$315.88 $779.14
52-week low $31.17$258.08 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleHNGECI
P/E now vs peer median 56.0xmedian 22.4x 13.0xmedian 25.2x
P/S now vs peer median 11.7xmedian 1.3x 0.3xmedian 0.4x
EV/EBITDA now vs peer median 40.0xmedian 14.2x 8.1xmedian 14.5x
P/FCF now vs peer median 29.1xmedian 19.0x 9.5xmedian 16.5x
P/B now vs peer median 31.3xmedian 2.6x 1.8xmedian 2.7x
PEG now vs peer median —median 0.84 1.59median 1.72

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsHNGECI
Revenue $800.82M $286.32B
Gross profit $686.54M $59.13B
Operating income $150.09M $9.78B
Net income $168.31M $6.71B
Free cash flow $322.00M $8.27B
R&D $134.62M –
EPS (diluted) $1.93 $22.71
Cash & equivalents $211.55M $6.19B
Total debt – $31.14B
Shares (diluted) 86.53M 263.79M
Enterprise value $7.82B $46.10B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricHNGECI
P/E 56.0x 13.0x
P/FCF 29.1x 9.5x
P/Operating cash flow 29.0x 8.3x
P/S 11.7x 0.3x
P/B 31.3x 1.8x
P/Tangible book 40.6x 4.6x
EV/EBITDA 40.0x 8.1x
EV/EBIT 60.5x 10.4x
EV/Revenue 11.3x 0.4x
EV/FCF 28.2x 12.4x
EV/Operating cash flow 28.1x 10.8x
PEG (3Y EPS CAGR) – 1.59

Growth

14 metrics
MetricHNGECI
Revenue growth (1Y) 49.9% 6.8%
Revenue CAGR (3Y) – 14.7%
Gross profit growth (1Y) 63.4% -4.4%
Gross profit CAGR (3Y) – -0.1%
Operating income growth (1Y) 127.2% 8.3%
Operating income CAGR (3Y) – 5.9%
Net income growth (1Y) 131.6% 2.4%
Net income CAGR (3Y) – 6.9%
EPS growth (1Y) 135.4% -1.2%
EPS CAGR (3Y) – 8.2%
Operating cash flow growth (1Y) 121.4% 8.8%
Operating cash flow CAGR (3Y) – -8.8%
Free cash flow growth (1Y) 121.4% 11.1%
Free cash flow CAGR (3Y) – -8.8%

Profitability

14 metrics
MetricHNGECI
Gross margin 85.7% 20.7%
EBITDA margin 28.3% 4.4%
Operating margin 18.7% 3.4%
Pretax margin 20.8% 2.9%
Net margin 20.8% 2.1%
FCF margin 40.2% 2.9%
Operating cash flow margin 40.3% 3.3%
Return on equity 52.2% 15.5%
Return on assets 19.7% 4.3%
Return on invested capital – 10.4%
Return on capital employed 49.0% 9.6%
Asset turnover 0.9x 1.8x
Cash conversion (OCF / net income) 1.9x 1.4x
Stock comp / revenue 8.4% –

Financial Health

11 metrics
MetricHNGECI
Debt / assets – 19.8%
Debt / equity – 0.7x
Net debt / EBITDA – 1.9x
Debt / FCF – 3.8x
Liabilities / assets 65.7% 72.3%
Equity / assets 34.3% 27.7%
Interest coverage – –
Current ratio 1.0x 0.8x
Quick ratio 0.9x 0.7x
Cash ratio 0.5x 0.1x
Altman Z-score 9.84 2.82

Shareholder Returns

7 metrics
MetricHNGECI
Dividend yield – 2.1%
Net buyback yield 2.2% 1.7%
Shareholder yield 2.2% 3.8%
Payout ratio (earnings) – 24.3%
Payout ratio (FCF) – 19.7%
Dividend growth (1Y) – 2.1%
Dividend CAGR (3Y) – 4.6%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusHNGECI
Forward P/E 42.9xFY2026 9.1xFY2026
EPS, next fiscal year $2.69FY2026 $32.48FY2026
EPS growth, next FY +2.7%FY2026 +8.8%FY2026
EPS growth, the year after +20.8% +8.7%
Revenue, next fiscal year $899.57MFY2026 $304.63BFY2026
Revenue growth, next FY +53.0%FY2026 +10.8%FY2026
Revenue growth, the year after +29.5% -6.8%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersHNGECI
Held by institutions 92.1% 89.7%
Institutions holding 279 1,704
Change in shares held, QoQ +2.5% +0.9%
Institutions buying 198 838
Institutions selling 66 576
Buyers to sellers 3.00 1.45

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

HNGECI
HNGE 1.00 0.09
CI 0.09 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, HNGE and CI?

Cigna (CI) is the largest by market capitalisation: Hinge Health (HNGE) $9.19B, Cigna (CI) $77.24B.

Which stock is cheaper, HNGE and CI?

Cigna (CI) trades on the lowest price-to-earnings ratio (Hinge Health (HNGE) 55.1x, Cigna (CI) 12.9x). On next year's consensus earnings, Cigna (CI) is cheapest (Hinge Health (HNGE) 42.9x, Cigna (CI) 9.1x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Hinge Health (HNGE) grew revenue fastest over the trailing twelve months: Hinge Health (HNGE) +49.9%, Cigna (CI) +6.8%.

Which company is more profitable?

Hinge Health (HNGE) has the highest net margin (Hinge Health (HNGE) 20.8%, Cigna (CI) 2.1%).

Which stock has performed better?

Over the past year Hinge Health (HNGE) returned the most: Hinge Health (HNGE) +196.0%, Cigna (CI) +11.3%. Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Hinge Health (HNGE) 0.00%, Cigna (CI) 0.02%. Hinge Health (HNGE) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Cigna (CI) has been the steadiest (Hinge Health (HNGE) 51.1%, Cigna (CI) 27.1%). Volatility measures how widely the price swings, not the risk of the business.

Do HNGE and CI move together?

Their daily returns over the past year have a correlation of 0.09, a weak relationship. Holding both diversifies more than two closely linked stocks would.

Which is the better stock, HNGE and CI?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Cigna (CI) leads on 4. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.